Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen

Clin Oncol (R Coll Radiol). 1996;8(6):402-3. doi: 10.1016/s0936-6555(96)80093-8.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Female
  • Hemolytic-Uremic Syndrome / chemically induced*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Middle Aged
  • Mitomycin / administration & dosage
  • Mitomycin / adverse effects*
  • Tamoxifen / administration & dosage
  • Tamoxifen / adverse effects*

Substances

  • Tamoxifen
  • Mitomycin